Users are already reporting measurable changes in muscle size, significant strength gains, and even improved blood work
As anticipated, Rx spend for GLP-1 users was higher compared to those not on GLP-1s
At present, the GLP-1 receptor agonists exendin-4 (Exenatide, Byetta , Bydureon ) (44, 45), liraglutide (Victoza ) (46), albiglutide [Eperzan (EU) Tanzeum (US)] (47, 48), dulaglutide (Trulicity ) (49), lixisenatide (Lyxumia , Adlyxin ) (50), semaglutide (Ozempic , Rybelsus ) (51, 52), are approved to treat T2DM (53) (see Table 1)
I live in Dallas and happened to be in Houston for work
Enter your email address
Here's what you can expect, backed by real data and patient experiences: Sustainable Results : Achieve an average 1520% body weight loss with GLP-1 agonists (like semaglutide or tirzepatide) plus personalized lifestyle coaching, as shown in clinical studies